Buckberg v. Edwards Lifesciences Research Medical CA2/4

CourtCalifornia Court of Appeal
DecidedMay 31, 2013
DocketB240053
StatusUnpublished

This text of Buckberg v. Edwards Lifesciences Research Medical CA2/4 (Buckberg v. Edwards Lifesciences Research Medical CA2/4) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Buckberg v. Edwards Lifesciences Research Medical CA2/4, (Cal. Ct. App. 2013).

Opinion

Filed 5/31/13 Buckberg v. Edwards Lifesciences Research Medical CA2/4 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION FOUR

GERALD D. BUCKBERG, B240053

Plaintiff and Appellant, (Los Angeles County Super. Ct. No. BC387528) v.

EDWARDS LIFESCIENCES RESEARCH MEDICAL, INC.,

Defendant and Respondent.

APPEAL from a judgment of the Superior Court of Los Angeles County, Terry A. Green, Judge. Reversed and remanded with directions. Krane & Smith, Marc Smith, and Douglas L. Day for Plaintiff and Appellant. Kilpatrick Townsend & Stockton, A. James Isbester, and Douglas A. McManamon for Defendant and Respondent.

_________________________________ INTRODUCTION Gerald D. Buckberg, M.D. appeals from a judgment following appeal entered December 2, 2011. He contends the superior court erred in calculating the amount of damages. Specifically, he contends (1) that he is entitled to postjudgment interest on the prejudgment interest included in the original judgment, and (2) that the trial court erred in calculating the amount of postjudgment royalties. We conclude that appellant is entitled to postjudgment interest on the prejudgment interest, and that he is entitled to a higher amount of postjudgment royalties. Accordingly, we reverse and remand for further proceedings. FACTUAL AND PROCEDURAL BACKGROUND The facts underlying this dispute are stated in this court‟s unpublished written decision in Buckberg v. Edwards Lifesciences Research Medical, Inc. (June 13, 2011, B219245). Essentially, the parties entered into two contracts (the Antegrade Agreement and the CSC Agreement) that provided royalty payments to appellant based upon a percentage of the net revenues from the sales or lease of certain medical devices. In 2007, the parties disputed respondent‟s obligations under the contracts, and whether respondent had extended the contracts. After a bench trial, a judgment largely in favor of appellant was entered on August 25, 2009. The judgment established that respondent Edwards Lifesciences Research Medical, Inc. (Edwards) owed appellant the “principal sum of $3,689,028 through July 31, 2009,” based in part upon a royalty rate of 8½% because the agreements were extended. This sum consisted of royalty payments and prejudgment interest on the royalty payments. The judgment also provided that appellant was entitled to a declaration that respondent was obligated to pay him (1) royalties at a 7% rate from January 1, 2009 until September 21, 2009 for the sales or lease of medical

2 devices covered under the Antegrade Agreement, and (2) royalties at a 7% rate from July 1, 2009 until July 13, 2010 for the sales or lease of medical devices under the CSC Agreement. Finally, the judgment provided that “[a]ll sums awarded hereunder shall further bear postjudgment interest at the rate of 10% per annum from the date of entry of judgment until paid.” Both parties filed timely 1 appeals. On June 13, 2011, this court affirmed the trial court‟s general interpretation of the contracts, but found that the contracts had not been extended. Because the contracts had not been extended, appellant was entitled to only a 7% royalty rate until the expiration of certain medical device patents (September 21, 2009 under the Antegrade Agreement, and July 13, 2010 under the CSC Agreement). We remanded the matter to the trial court to “recalculate damages.” Following this court‟s decision, the trial court set a status conference for July 23, 2011. Prior to that date, respondent‟s counsel provided appellant‟s counsel with data to evaluate the amount of royalties. At the July 23, 2011 hearing, appellant‟s counsel was not prepared to provide appellant‟s position on the amount of royalties owed. The trial court set another status conference for August 26, 2011. The August 26 hearing was later continued to November 4, 2011. Because of the delay and the accrual of postjudgment interest, on November 4, 2011, respondent paid appellant $3,801,429 to satisfy the outstanding judgment. Respondent also filed a proposed judgment following appeal. Appellant was not satisfied with the amount, and filed objections, claiming that respondent had miscalculated the amount of damages. Appellant asserted that “[w]hile [respondent] did previously send [appellant] post judgment royalty reports

1 In its appeal, Edwards did not challenge the award of postjudgment interest on the entire amount of the judgment, including prejudgment interest.

3 for the period from August 1, 2009 to July 10, 2010, both counsel have misplaced them. . . . Such reports are necessary for [appellant] to verify the amount of post judgment royalties and the interest calculation.” Appellant stated he did not object to the following calculations: (1) the amount of royalties owed under the agreements from January 1, 2007 to December 31, 2008 was $1,771,661; (2) the sum of the prejudgment interest on that amount (covering January 1, 2007 to December 31, 2008) was $255,849; (3) the amount of daily postjudgment interest on the $1,771,661 amount was $487.03; (4) as of November 4, 2011, the daily postjudgment interest amount should be multiplied by 826 days; and (5) costs were $11,500. Appellant objected to the calculation of royalties ($438,919) and prejudgment interest ($5,500) for the period January 1, 2009 to July 31, 2009 “due to lack of information.” Appellant also contended that the total interest on the amount of costs ($11,500) was $2,605.11, not $2,300, because the daily interest was $31.54. Respondent filed a response, noting that “[w]hile Buckberg‟s counsel may have misplaced [the postjudgment royalty reports], Edwards‟ counsel did not. Indeed, . . . Edwards‟ counsel forwarded additional copies of the reports on Tuesday, November 15.” Respondent also stated that appellant‟s objections made “no sense,” as the numbers came “directly from the Court‟s Statement of Decision.” Finally, respondent contended that its calculation of interest on costs was correct. Respondent asserted that the total interest on costs was $2,300, based upon a daily interest of $3.15 per day multiplied by 725 days, the number of days from the date the order on costs was entered (November 9, 2009) until November 4, 2011. The trial court issued an order to show cause (OSC) re entry of judgment and set a hearing date on the OSC for November 18, 2011. At the November 18 hearing, the trial court accepted respondent‟s numbers on all points, but asked the

4 parties to brief whether appellant was entitled to postjudgment interest on the award of prejudgment interest. In appellant‟s briefing, he conceded that the corrected original judgment was $2,471,929, consisting of: $1,771,661 in royalties for the period January 1, 2007 through December 31, 2008; $255,849 in prejudgment interest on that amount; $438,919 in royalties from January 1, 2009 through July 31, 2009; and $5,500 in prejudgment interest on that amount. Appellant agreed that costs were $11,500, but calculated total interest on costs at $2,602.40 Appellant further calculated that the postjudgment royalties for the period August 1, 2009 through July 13, 2010 under both agreements totaled $793,860.62. He alleged that this figure was the amount reported by respondent. Respondent filed a reply, contending that appellant was not entitled to compound interest under the California Constitution and relevant case law. In a separate pleading, respondent asserted that the total amount of postjudgment royalties for the period August 1, 2009 through July 13, 2010 was $745,235.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Big Bear Properties, Inc. v. Gherman
95 Cal. App. 3d 908 (California Court of Appeal, 1979)
Mendez v. Kurten
170 Cal. App. 3d 481 (California Court of Appeal, 1985)
Westbrook v. Fairchild
7 Cal. App. 4th 889 (California Court of Appeal, 1992)
OCM Principal Opportunities Fund, L.P. v. CIBC World Markets Corp.
168 Cal. App. 4th 185 (California Court of Appeal, 2008)
Hess v. Ford Motor Co.
41 P.3d 46 (California Supreme Court, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Buckberg v. Edwards Lifesciences Research Medical CA2/4, Counsel Stack Legal Research, https://law.counselstack.com/opinion/buckberg-v-edwards-lifesciences-research-medical-c-calctapp-2013.